From inflammation to cancer
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The participation of inflammation in the progression of cancer for many years have been the subject of research. METHODS: In the 19th century, there was evidence that an acute inflammation may inhibit the development of cancer. However, chronic inflammation affects the progression of the disease. RESULTS: Today, it is known that inflammation and cancer use similar mechanisms of development such as severe cell proliferation or angiogenesis. It has been shown that prolonged presence of inflammatory cells and factors in the tumor microenvironment can accelerate its growth and inhibit apoptosis of transformed cells. CONCLUSION: In this article we present a brief history of the discovery mechanisms and potential links between acute and chronic inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Changes of IRFs are not limited to neuropsychiatric disorders; they are also reported in patients with cardiovascular and metabolic diseases66, as well as cancer67,68.”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 2×
“Currently, we know that irrespective of the triggering agent, tissue damage activates signals that initiate and support the immune response of the host, able to eliminate a damaging agent and to repair tissues [8].”
BackgroundMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472 · cited 1×
“Other cells include monocytes and lymphocytes initiating healing and generation of immunological memory [25].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Moreover, the author observed that the cells involved in inflammation also infiltrated cancer tissue [2, 3] and defined cancer as a ‘‘wound that does not heal’’.”
BackgroundGetting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 1×
“Apart from PECAM-1, such distribution is also characteristic of CD99 protein [21, 22].”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“This is associated, among others, with the production by the transforming cancer cells of many cytokines and chemokines which attract various populations of immune cells, including macrophages, neutrophils, adipose cells, dendritic cells and T, B and NK cells, which in turn infiltrate tumor tissues and form tumor micr…”
Background
Research works printed but not linked: 2
- Kołaczkowska E (2007) Acute inflammation as a beneficial process—history and recent developments. Kosmos 56:27–38
- Muller WA (2007) PECAM: Regulating the start of diapedesis. In: Adhesion molecules: function and inhibition. Progress in inflammation research, pp 201–220. doi: 10.1007/978-3-7643-7975-9-8 · doi:10.1007/978-3-7643-7975-9-8
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
“The intricate relationship between cancer and, prolonged inflammation has been thoroughly investigated since Virchow’s hypothesis [28].”
BackgroundInflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
“The sustained presence of inflammatory cells in the tumour milieu can stimulate tumour growth, hindering apoptosis of atypically transformed cells [91].”
BackgroundRole of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
Bhat, A. A., Uppada, S., Achkar, I. W., Hashem, S., Yadav, S. K., Shanmugakonar, M., Al-Naemi, H. A., Haris, M., & Uddin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01942 · Cited by 400
“As TJ barrier dysfunction and inflammation are tightly associated with each other, equally inflammation and cancer are closely linked (Coussens and Werb, 2002; Raposo et al., 2015; Korniluk et al., 2017).”
Background
Metadata
- Authors
- Korniluk, A., Koper, O., Kemona, H., & Dymicka-Piekarska, V.
- Affiliations
- Medical University of Białystok (PL)
- Corresponding author
- Dymicka-Piekarska, V.
- Venue
- Irish Journal of Medical Science (1971 -)
- Published
- 2016-05-07
- Volume
- 186
- Issue
- 1
- Pages
- 57-62
- ISSN
- 0021-1265 (ISSN-L)
- 1863-4362
- PMC
- PMC5323483
- OpenAlex
- W2345630246
- Cited by
- 282
- References
- 43
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 24 · 2023: 36 · 2022: 46 · 2021: 50 · 2020: 30 · 2019: 33 · 2018: 19 · 2017: 9 · 2016: 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Irish Journal of Medical Science (1971 -) (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Medyczny w Bialymstoku (PL) (N/ST/ZB/15/002/2209)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- inflammation, tumor progression, chronic inflammation, acute inflammation, tumor microenvironment, angiogenesis, cell proliferation, apoptosis
- MeSH terms
- Humans, Inflammation, Neoplasms, Neovascularization, Pathologic, Apoptosis, Disease Progression, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From inflammation to cancer. https://app.cochat.ai/papers/10.1007/s11845-016-1464-0
- The paper
- Korniluk, A., Koper, O., Kemona, H., & Dymicka-Piekarska, V. (2017). From inflammation to cancer. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-016-1464-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.